Acura Pharmaceuticals - 25 Year Stock Price History | ACUR
Historical daily share price chart and data for Acura Pharmaceuticals since 1992 adjusted for splits and dividends. The latest closing stock price for Acura Pharmaceuticals as of February 22, 2017 is 0.62.
- The all-time high Acura Pharmaceuticals stock closing price was 544.00 on December 31, 1992.
- The Acura Pharmaceuticals 52-week high stock price is 0.00, which is -100% above the current share price.
- The Acura Pharmaceuticals 52-week low stock price is 0.00, which is 100% below the current share price.
- The average Acura Pharmaceuticals stock price for the last 52 weeks is NaN.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Acura Pharmaceuticals Historical Annual Stock Price Data |
| Year |
Average Stock Price |
Year Open |
Year High |
Year Low |
Year Close |
Annual % Change |
| 2017 |
0.7319 |
0.8400 |
1.3000 |
0.4950 |
0.6200 |
-19.11% |
| 2016 |
1.8810 |
2.2700 |
3.4400 |
0.7400 |
0.7665 |
-69.34% |
| 2015 |
3.2919 |
2.5000 |
5.1500 |
1.6900 |
2.5000 |
11.11% |
| 2014 |
5.5121 |
8.4000 |
10.1500 |
2.1500 |
2.2500 |
-73.05% |
| 2013 |
9.8972 |
11.6000 |
15.2000 |
7.0000 |
8.3500 |
-24.77% |
| 2012 |
12.9750 |
17.4000 |
20.7000 |
5.5000 |
11.1000 |
-36.39% |
| 2011 |
18.3555 |
17.3000 |
26.4000 |
12.7500 |
17.4500 |
5.44% |
| 2010 |
17.8278 |
27.3500 |
39.5000 |
11.3500 |
16.5500 |
-37.90% |
| 2009 |
29.0301 |
37.4000 |
42.5500 |
20.1500 |
26.6500 |
-27.38% |
| 2008 |
38.5968 |
32.7500 |
49.8500 |
20.0500 |
36.7000 |
20.33% |
| 2007 |
57.7038 |
35.0000 |
124.5000 |
30.5000 |
30.5000 |
-17.57% |
| 2006 |
33.0498 |
14.5000 |
50.0000 |
14.0000 |
37.0000 |
164.29% |
| 2005 |
28.3909 |
17.5000 |
58.0000 |
14.0000 |
14.0000 |
-22.22% |
| 2004 |
25.2679 |
22.5000 |
37.5000 |
17.0000 |
18.0000 |
-20.00% |
| 2003 |
42.1587 |
49.0000 |
75.0000 |
13.0000 |
22.5000 |
-51.61% |
| 2002 |
85.5794 |
105.0000 |
138.5000 |
37.5000 |
46.5000 |
-52.31% |
| 2001 |
97.4839 |
35.0000 |
164.0000 |
35.0000 |
97.5000 |
178.57% |
| 2000 |
59.7897 |
56.5000 |
119.0000 |
23.5000 |
35.0000 |
-25.53% |
| 1999 |
93.5556 |
75.0000 |
150.0000 |
47.0000 |
47.0000 |
-31.88% |
| 1998 |
107.3611 |
87.5000 |
162.5000 |
50.0000 |
69.0000 |
-11.54% |
| 1997 |
199.0415 |
294.0000 |
297.0000 |
72.0000 |
78.0000 |
-74.55% |
| 1996 |
255.8268 |
187.5000 |
372.0000 |
184.5000 |
306.5000 |
72.19% |
| 1995 |
142.7004 |
103.0000 |
212.5000 |
75.0000 |
178.0000 |
67.14% |
| 1994 |
164.1508 |
250.0000 |
250.0000 |
81.5000 |
106.5000 |
-57.40% |
| 1993 |
305.1739 |
487.5000 |
525.0000 |
187.5000 |
250.0000 |
-54.04% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.000B |
$0.002B |
|
Halsey Drug Company, Inc. is engaged in the manufacture, sale and distribution of generic drugs. A generic drug is the chemical and therapeutic equivalent of a brand-name drug for which patent protection has expired. The company sells its generic drug products under its Halsey label and under private-label arrangements with drugstore chains and drug wholesalers.
|
